Low FasL levels promote proliferation of human bone marrow-derived mesenchymal stem cells, higher levels inhibit their differentiation into adipocytes

Cell Death and Disease

Volumn 4, Issue 4, 2013, Pages

  Rippo, M R ^a   Babini, L ^a   Prattichizzo, F ^a   Graciotti, L ^a   Fulgenzi, G ^a,b   Tomassoni Ardori, F ^b   Olivieri, F ^a,c   Borghetti, G ^a   Cinti, S ^a   Poloni, A ^a   Fazioli, F ^a   Procopio, A D ^a,b  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b NATIONAL CANCER INSTITUTE   (United States)

^c INRCA   (Italy)

Author keywords

Adipogenesis; Bone marrow derived mesenchymal stem cells; Fas ligand; Peroxisome proliferator activated receptor gamma; Proliferation

Indexed keywords

FAS LIGAND; MITOGEN ACTIVATED PROTEIN KINASE 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; BIRC5 PROTEIN, HUMAN; CASPASE; FABP4 PROTEIN, HUMAN; FATTY ACID BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; NEUTRALIZING ANTIBODY; RECOMBINANT PROTEIN;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; IN VITRO STUDY; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSTEOPOROSIS; PHENOTYPE; PRIORITY JOURNAL; UPREGULATION; ANIMAL; BIOSYNTHESIS; BONE MARROW CELL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DRUG EFFECT; GENETICS; HUMAN; IMMUNOLOGY; MESENCHYMAL STROMA CELL; METABOLISM; TIBIA; TRANSGENIC MOUSE;

MUS;

ADIPOGENESIS; ANIMALS; ANTIBODIES, NEUTRALIZING; BONE MARROW CELLS; CASPASES; CELL PROLIFERATION; CELLS, CULTURED; FAS LIGAND PROTEIN; FATTY ACID-BINDING PROTEINS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PPAR GAMMA; RECOMBINANT PROTEINS; TIBIA;

EID: 84876898565     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.115     Document Type: Article

References (38)

1. Bertolotti A, Zhang Y, Hendershot LM, Harding HP, Ron D. Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat Cell Biol 2000; 2: 326-332
2. Oikawa D, Kimata Y, Kohno K, Iwawaki T. Activation of mammalian IRE1alpha upon ER stress depends on dissociation of BiP rather than on direct interaction with unfolded proteins. Exp Cell Res 2009; 315: 2496-2504
3. Sidrauski C, Cox JS, Walter P. tRNA ligase is required for regulated mRNA splicing in the unfolded protein response. Cell 1996; 87: 405-413
4. Cox JS, Shamu CE, Walter P. Transcriptional induction of genes encoding endoplasmic reticulum resident proteins requires a transmembrane protein kinase. Cell 1993; 73: 1197-1206
5. Messner DJ, Kowdley KV. Biting the iron bullet: Endoplasmic reticulum stress adds the pain of hepcidin to chronic liver disease. Hepatology 2010; 51: 705-707
6. Ji C, Kaplowitz N. ER stress: Can the liver cope? J Hepatol 2006; 45: 321-333
7. Malhi H, Kaufman RJ. Endoplasmic reticulum stress in liver disease. J Hepatol 2011; 54: 795-809
8. Wang Y, Vera L, Fischer WH, Montminy M. The CREB coactivator CRTC2 links hepatic ER stress and fasting gluconeogenesis. Nature 2009; 460: 534-537
9. Birkenfeld AL, Lee HY, Majumdar S, Jurczak MJ, Camporez JP, Jornayvaz FR et al. Influence of the hepatic eukaryotic initiation factor 2alpha (eIF2alpha) endoplasmic reticulum (ER) stress response pathway on insulin-mediated ER stress and hepatic and peripheral glucose metabolism. J Biol Chem 2011; 286: 36163-36170
10. Zhang K, Wang S, Malhotra J, Hassler JR, Back SH, Wang G et al. The unfolded protein response transducer IRE1alpha prevents ER stress-Induced hepatic steatosis. EMBO J 2011; 30: 1357-1375
11. Ai D, Baez JM, Jiang H, Conlon DM, Hernandez-Ono A, Frank-Kamenetsky M et al. Activation of ER stress and mTORC1 suppresses hepatic sortilin-1 levels in obese mice. J Clin Invest 2012; 122: 1677-1687
12. Ramirez T, Tong M, Chen WC, Nguyen QG, Wands JR, de la Monte SM. Chronic alcoholinduced hepatic insulin resistance and ER stress ameliorated by PPAR-delta agonist treatment. J Gastroenterol Hepatol 2012; 28: 179-187
13. Hofmann AF. Cholestatic liver disease: Pathophysiology and therapeutic options. Liver 2002; 22(Suppl 2): 14-19
14. Reinehr R, Graf D, Haussinger D. Bile salt-Induced hepatocyte apoptosis involves epidermal growth factor receptor-dependent CD95 tyrosine phosphorylation. Gastroenterology 2003; 125: 839-853
15. Schmucker DL, Ohta M, Kanai S, Sato Y, Kitani K. Hepatic injury induced by bile salts: Correlation between biochemical and morphological events. Hepatology 1990; 12: 1216-1221
16. Bernstein H, Payne CM, Bernstein C, Schneider J, Beard SE, Crowley CL. Activation of the promoters of genes associated with DNA damage, oxidative stress, ER stress and protein malfolding by the bile salt, deoxycholate. Toxicol Lett 1999; 108: 37-46
17. Bochkis IM, Rubins NE, White P, Furth EE, Friedman JR, Kaestner KH. Hepatocytespecific ablation of Foxa2 alters bile acid homeostasis and results in endoplasmic reticulum stress. Nat Med 2008; 14: 828-836
18. Tamaki N, Hatano E, Taura K, Tada M, Kodama Y, Nitta T et al. CHOP deficiency attenuates cholestasis-Induced liver fibrosis by reduction of hepatocyte injury. Am J Physiol Gastrointest Liver Physiol 2008; 294: G498-G505
19. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297
20. Ouyang YB, Lu Y, Yue S, Xu LJ, Xiong XX, White RE et al. miR-181 regulates GRP78 and influences outcome from cerebral ischemia in vitro and in vivo. Neurobiol Dis 2012; 45: 555-563
21. Su SF, Chang YW, Andreu-Vieyra C, Fang JY, Yang Z, Han B et al. miR-30d, miR-181a and miR-199a-5p cooperatively suppress the endoplasmic reticulum chaperone and signaling regulator GRP78 in cancer. Oncogene 2012
22. O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 2010; 10: 111-122
23. Sheedy FJ, Palsson-McDermott E, Hennessy EJ, Martin C, O'Leary JJ, Ruan Q et al. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol 2010; 11: 141-147
24. Kanda T, Ishibashi O, Kawahigashi Y, Mishima T, Kosuge T, Mizuguchi Y et al. Identification of obstructive jaundice-related microRNAs in mouse liver. Hepatogastroenterology 2010; 57: 1013-1023
25. Murakami Y, Toyoda H, Tanaka M, Kuroda M, Harada Y, Matsuda F et al. The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families. PLoS One 2011; 6: E16081
26. Shen Q, Cicinnati VR, Zhang X, Iacob S, Weber F, Sotiropoulos GC et al. Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion. Mol Cancer 2010; 9: 227
27. Bernt C, Vennegeerts T, Beuers U, Rust C. The human transcription factor AP-1 is a mediator of bile acid-Induced liver cell apoptosis. Biochem Biophys Res Commun 2006; 340: 800-806
28. Fuest M, Willim K, MacNelly S, Fellner N, Resch GP, Blum HE et al. The transcription factor c-Jun protects against sustained hepatic endoplasmic reticulum stress thereby promoting hepatocyte survival. Hepatology 2012; 55: 408-418
29. Chan YC, Roy S, Huang Y, Khanna S, Sen CK. The microRNA miR-199a-5p downregulation switches on wound angiogenesis by de-repressing the v-ets erythroblastosis virus E26 oncogene homolog 1 -matrix metalloproteinase-1 pathway. J Biol Chem 2012; 287: 41032-41043
30. Shatseva T, Lee DY, Deng Z, Yang BB. MicroRNA miR-199a-3p regulates cell proliferation and survival by targeting caveolin-2. J Cell Sci 2011; 124(Pt 16): 2826-2836
31. Tsukigi M, Bilim V, Yuuki K, Ugolkov A, Naito S, Nagaoka A et al. Re-expression of miR-199a suppresses renal cancer cell proliferation and survival by targeting GSK-3beta. Cancer Lett 2012; 315: 189-197
32. Xu N, Zhang J, Shen C, Luo Y, Xia L, Xue F et al. Cisplatin-Induced downregulation of miR-199a-5p increases drug resistance by activating autophagy in HCC cell. Biochem Biophys Res Commun 2012; 423: 826-831
33. Haghikia A, Missol-Kolka E, Tsikas D, Venturini L, Brundiers S, Castoldi M et al. Signal transducer and activator of transcription 3-mediated regulation of miR-199a-5p links cardiomyocyte and endothelial cell function in the heart: A key role for ubiquitin-conjugating enzymes. Eur Heart J 2011; 32: 1287-1297
34. Henry JC, Park JK, Jiang J, Kim JH, Nagorney DM, Roberts LR et al. miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines. Biochem Biophys Res Commun 2010; 403: 120-125
35. Fornari F, Milazzo M, Chieco P, Negrini M, Calin GA, Grazi GL et al. MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res 2010; 70: 5184-5193
36. Hou J, Lin L, Zhou W, Wang Z, Ding G, Dong Q et al. Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 2011; 19: 232-243
37. Crighton D, Wilkinson S, Ryan KM. DRAM links autophagy to p53 and programmed cell death. Autophagy 2007; 3: 72-74
38. Zhang J, Cheng C, He CL, Zhou YJ, Cao Y. The expression of Bcl-XL, Bcl-XS and p27Kip1 in topotecan-Induced apoptosis in hepatoblastoma HepG2 cell line. Cancer Invest 2008; 26: 456-463